Skip to main content
. 2019 Sep 21;9(10):197. doi: 10.3390/metabo9100197

Figure 5.

Figure 5

Antitumoural activity profiles (HepG2, MCF-7 and Miacapa-2) marked as a black dashed line overlapping the semi-preparative HPLC fractions for each active fermentation conditions of the strain CF-090383 in MMK2 medium: (A) supplemented with XAD-16 resin; (B) supplemented with 5-azacytidine, and (C) supplemented with valproic acid. Predicted molecular formulas by HR-MS for the main component of each active fraction are indicated in bold.